BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16053357)

  • 21. Management of adult Leydig-cell testicular tumors: assessing the role of laparoscopic retroperitoneal lymph node dissection.
    Peschel R; Gettman MT; Steiner H; Neururer R; Bartsch G
    J Endourol; 2003 Nov; 17(9):777-80. PubMed ID: 14642042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: a large single institution experience.
    Hyams ES; Pierorazio P; Proteek O; Sroka M; Kavoussi LR; Allaf ME
    J Urol; 2012 Feb; 187(2):487-92. PubMed ID: 22177913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population.
    Glaser AP; Bowen DK; Lindgren BW; Meeks JJ
    J Pediatr Urol; 2017 Apr; 13(2):223-224. PubMed ID: 28262537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laparoscopic Retroperitoneal Lymph Node Dissection as a Safe Procedure for Postchemotherapy Residual Mass in Testicular Cancer.
    Faria EF; Neves HS; Dauster B; Machado RD; Magnabosco WJ; Muller RL; Santos AC; Tobias-Machado M
    J Laparoendosc Adv Surg Tech A; 2018 Feb; 28(2):168-173. PubMed ID: 29215949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laparoscopic retroperitoneal lymph node dissection with therapeutic intent in men with clinical stage I nonseminomatous germ cell tumors.
    Guzzo TJ; Gonzalgo ML; Allaf ME
    J Endourol; 2010 Nov; 24(11):1759-63. PubMed ID: 20879859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer: current status.
    Bhayani SB; Allaf ME; Kavoussi LR
    Urol Oncol; 2004; 22(2):145-8. PubMed ID: 15082014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center's retrospective analysis.
    Tong S; Chen M; Zu X; Li Y; He W; Lei Y; Liu W; Qi L
    Int Urol Nephrol; 2014 Feb; 46(2):363-9. PubMed ID: 23996573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
    Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
    Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: a long-term update.
    Bhayani SB; Ong A; Oh WK; Kantoff PW; Kavoussi LR
    Urology; 2003 Aug; 62(2):324-7. PubMed ID: 12893344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic retroperitoneal lymph-node dissection with the waterjet is technically feasible and safe in testis-cancer patient.
    Corvin S; Sturm W; Schlatter E; Anastasiadis A; Kuczyk M; Stenzl A
    J Endourol; 2005 Sep; 19(7):823-6. PubMed ID: 16190836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma.
    Corvin S; Kuczyk M; Anastasiadis A; Stenzl A
    World J Urol; 2004 Apr; 22(1):33-6. PubMed ID: 15034741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors infiltrating the great vessels.
    Aufderklamm S; Todenhöfer T; Hennenlotter J; Mischinger J; Böttge J; Rausch S; Halalsheh O; Stenzl A; Gakis G; Schwentner C
    J Endourol; 2014 Jun; 28(6):668-74. PubMed ID: 24422683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacy.
    Nicolai N; Nazzani S; Tesone A; Macchi A; Piva L; Salvioni R; Stagni S; Torelli T; Agostini E; Celso F; Giannatempo P; Procopio G; Avuzzi B; Lanocita R; Cattaneo L; Catanzaro M; Biasoni D
    Tumori; 2023 Aug; 109(4):379-386. PubMed ID: 35915559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is modified retroperitoneal lymph node dissection alive for clinical stage I non-seminomatous germ cell testicular tumor?
    Basiri A; Ghaed MA; Simforoosh N; Tabibi A; Danesh A; Nouralizadeh A; Parizi MK
    Urol J; 2013; 10(2):873-7. PubMed ID: 23801470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-chemotherapy Laparoscopic Retroperitoneal Lymph Node Dissection for Mixed Malignant Germ Cell Testicular Tumors.
    Pickersgill NA; Raval NS; Kim EH; Black RG; Du K; Figenshau RS
    Clin Genitourin Cancer; 2021 Jun; 19(3):273.e1-273.e5. PubMed ID: 33139148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimally Invasive Retroperitoneal Lymphadenectomy: Current Status.
    Kunit T; Janetschek G
    Urol Clin North Am; 2015 Aug; 42(3):321-9. PubMed ID: 26216819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Open retroperitoneal lymph node dissection.
    Richie JP
    Can J Urol; 2005 Feb; 12 Suppl 1():37-9. PubMed ID: 15780163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary robotic retroperitoneal lymph node dissection following orchiectomy for testicular germ cell tumors: a single-surgeon experience.
    Supron AD; Cheaib JG; Biles MJ; Schwen Z; Allaf M; Pierorazio PM
    J Robot Surg; 2021 Apr; 15(2):309-313. PubMed ID: 32572754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life after laparoscopic and open retroperitoneal lymph node dissection in clinical Stage I nonseminomatous germ cell tumor: a comparison study.
    Poulakis V; Skriapas K; de Vries R; Dillenburg W; Ferakis N; Witzsch U; Becht E
    Urology; 2006 Jul; 68(1):154-60. PubMed ID: 16820195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
    J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.